Preclinical • Journal • Combination therapy • PD(L)-1 Biomarker • IO biomarker • Tumor cell
|
FGFR2 (Fibroblast growth factor receptor 2) • FGFR (Fibroblast Growth Factor Receptor)
|
FGFR2 expression • FGFR2b expression
|
Tecentriq (atezolizumab) • Pemazyre (pemigatinib) • derazantinib (ARQ 087)